Standard Soy Milk for non-alcoholic fatty liver disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 15 Nov 2023: Trial registered, NCT06133101
  2. 15 Jan 2024: Trial started, NCT06133101

The trials

NCT06133101: Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)

State
Under way
Phase
Phase 2
People
44 planned
Started
15 Jan 2024
Primary completion
Mar 2028
Arms
Standard Soy Milk
Results
None posted
  1. 15 Nov 2023: Trial registered
  2. 15 Jan 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.